CUE BIOPHARMA INC. - COMMON STOCK

0.7608

30-April-25 15:06:17

15 minutes delayed

Stocks

-0.0038

-0.50%

Today's range

0.7336 - 0.7906

ISIN

N/A

Source

NASDAQ

Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference

15 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
Cue Biopharma to Host Business Update Call and Webcast

09 Mar 2021 08:00:00 By Nasdaq GlobeNewswire
Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference

01 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos

25 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development

17 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer

08 Feb 2021 08:00:01 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.